|
|
|
|
|
|
|
|
|
|
Emcure Pharmaceuticals Ltd.
|
|
|
|
|
|
|
|
|
BSE Code |
544210
|
|
ISIN Demat |
INE168P01015
|
|
Book Value (Rs) |
159.59
|
|
|
NSE Code |
EMCURE
|
|
Dividend Yield % |
0.23
|
|
Market Cap(Rs Mn) |
242911.80
|
|
|
TTM PE(x) |
76.60
|
|
TTM EPS(Rs) |
16.73
|
|
Face Value (Rs) |
10
|
|
|
|
|
|
|
|
|
Industry : Pharmaceuticals & Drugs |
House : Private |
|
Incorporation Year
|
16-04 1981
|
|
Registered Office
|
Plot No. P-1 & P-2,I T - B T Park, Phase- I I,M I D C, Hinjawadi, Pune,
Maharashtra-411057 .
|
|
ISINNO
|
INE168P01015
|
|
Phone
|
020-3507003 / 35070000
|
|
E-mail
|
investors@emcure.com |
|
URL
|
www.emcure.com |
|
Industry
|
Pharmaceuticals & Drugs
|
|
Chairman
|
Berjis Minoo Desai
|
|
Managing Director
|
Satish Ramanlal Mehta
|
|
Company Secretary
|
Chetan Rajendra Sharma
|
|
Listing
|
BSE,NSE
|
|
|
|
|